Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Not applicableStudy completedNCT04540588What this trial is testingRetreatment With Intratumoral Diffusing Alpha Radiation EmittersWho this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 2
Very early researchLooking for participantsNCT06305962What this trial is testing177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsWho this might be right forPDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Looking for participantsNCT05267626What this trial is testingStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerWho this might be right forAdvanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more Aulos Bioscience, Inc. 159
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05075980What this trial is testingIntensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT StudyWho this might be right forHead and Neck CarcinomaHead and Neck Carcinoma of Unknown PrimaryHypopharyngeal Carcinoma+9 more Mayo Clinic 174
Testing effectiveness (Phase 2)Study completedNCT04592484What this trial is testingA First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid TumorsWho this might be right forAdvanced Solid Tumor Codiak BioSciences 27
Large-scale testing (Phase 3)Looking for participantsNCT06589804What this trial is testingTesting the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentWho this might be right forMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more National Cancer Institute (NCI) 158
Early research (Phase 1)Looking for participantsNCT06868433What this trial is testingTMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerWho this might be right forClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more Emory University
Not applicableLooking for participantsNCT03889899What this trial is testingAlpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.Who this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 30
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07602842What this trial is testingIDP-001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more InduPro, Inc. 132
Testing effectiveness (Phase 2)Ended earlyNCT04242173What this trial is testingCemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCCWho this might be right forCutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck H. Lee Moffitt Cancer Center and Research Institute 3
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047What this trial is testingStudy Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOWho this might be right forLung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more UNICANCER 646
Testing effectiveness (Phase 2)Study completedNCT03082534What this trial is testingPembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forHNSCCLip SCCOral Cavity Cancer+9 more University of California, San Diego 78
Testing effectiveness (Phase 2)Study completedNCT04454489What this trial is testingQuad Shot Radiotherapy in Combination With Immune Checkpoint InhibitionWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaMetastatic Head-and-neck Squamous-cell Carcinoma+3 more Wake Forest University Health Sciences 21
Not applicableUnknownNCT05845632What this trial is testingTime to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell CarcinomaWho this might be right forCarcinoma, Squamous CellSkin CancerCarcinoma, Squamous Cell, Skin+3 more Maastricht University Medical Center 965
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130